Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Civilization Ventures is a venture capital firm founded in 2017 and based in the United States. The firm manages over $200 million in assets and has partnered with more than 70 companies, emphasizing a founder-centric investment approach.
Civilization Ventures invests in pre-seed, seed, and Series A stages, targeting scientific founders in healthcare and biotech. Their investment thesis includes genomics, diagnostics, digital health, and synthetic biology, with a particular interest in gene editing and liquid biopsy technologies.
Notable portfolio companies include Foresight Diagnostics, which develops ultrasensitive diagnostics for early cancer detection; Rewrite Therapeutics, focusing on genome editing technologies; BillionToOne, innovating in prenatal disease detection; and Omada Health, offering virtual care solutions for chronic conditions.
Submit your pitch through their form at civilizationventures.com.
Yes, Civilization Ventures often leads investment rounds, particularly in early-stage companies within their focus sectors.
The firm is open to follow-on investments, especially for portfolio companies that demonstrate significant growth and potential.
Civilization Ventures manages a fund size of $200 million, which supports their investments in the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.